全文获取类型
收费全文 | 2440篇 |
免费 | 173篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 184篇 |
妇产科学 | 38篇 |
基础医学 | 290篇 |
口腔科学 | 58篇 |
临床医学 | 276篇 |
内科学 | 480篇 |
皮肤病学 | 34篇 |
神经病学 | 90篇 |
特种医学 | 512篇 |
外科学 | 205篇 |
综合类 | 44篇 |
一般理论 | 1篇 |
预防医学 | 152篇 |
眼科学 | 24篇 |
药学 | 142篇 |
中国医学 | 3篇 |
肿瘤学 | 94篇 |
出版年
2023年 | 7篇 |
2022年 | 18篇 |
2021年 | 30篇 |
2020年 | 22篇 |
2019年 | 32篇 |
2018年 | 45篇 |
2017年 | 23篇 |
2016年 | 38篇 |
2015年 | 49篇 |
2014年 | 52篇 |
2013年 | 97篇 |
2012年 | 78篇 |
2011年 | 59篇 |
2010年 | 94篇 |
2009年 | 73篇 |
2008年 | 78篇 |
2007年 | 82篇 |
2006年 | 61篇 |
2005年 | 51篇 |
2004年 | 42篇 |
2003年 | 38篇 |
2002年 | 38篇 |
2001年 | 37篇 |
2000年 | 46篇 |
1999年 | 51篇 |
1998年 | 135篇 |
1997年 | 124篇 |
1996年 | 132篇 |
1995年 | 96篇 |
1994年 | 81篇 |
1993年 | 89篇 |
1992年 | 35篇 |
1991年 | 36篇 |
1990年 | 29篇 |
1989年 | 74篇 |
1988年 | 48篇 |
1987年 | 57篇 |
1986年 | 51篇 |
1985年 | 51篇 |
1984年 | 33篇 |
1983年 | 39篇 |
1982年 | 40篇 |
1981年 | 24篇 |
1980年 | 36篇 |
1979年 | 16篇 |
1978年 | 28篇 |
1977年 | 30篇 |
1976年 | 28篇 |
1975年 | 29篇 |
1974年 | 11篇 |
排序方式: 共有2637条查询结果,搜索用时 15 毫秒
1.
S Lori Brown Roselie A Bright Diane E Dwyer Betsy Foxman 《Journal of human lactation》2005,21(2):169-174
Breast pumps are medical devices used to express milk and maintain the milk supply. The purpose of this study was to characterize adverse events reported to the United States Food and Drug Administration (FDA) on breast pumps. Thirty-seven adverse event reports on breast pumps were identified from the Manufacturer and User Facility Device Experience database between 1992 and 2003. Four additional reports were found in the Device Experience Network database from 1992 to 1996. The most commonly reported adverse events for electric breast pumps were pain, soreness, or discomfort; the need for medical intervention; and breast tissue damage. Most frequently reported problems for manual breast pumps were breast tissue damage and infection. Contamination of breast milk during pumping was also reported. Breast pump adverse events are likely underreported to the FDA. Reporting adverse events is important for improving the design and manufacture of breast pumps and subsequently decreasing adverse events. 相似文献
2.
J E Bright A C Woodman T C Marrs S G Wood 《Xenobiotica; the fate of foreign compounds in biological systems》1987,17(1):79-83
A methaemoglobin former, 4-aminopropiophenone (p-aminopropiophenone, PAPP), which is active only after metabolic activation in vivo, exhibits a sex difference in male Beagle dogs and bitches. Bitches produced more methaemoglobin for a given dose of PAPP than male dogs. The probable reason for this difference was a lower rate of N-hydroxylation in male dogs. 相似文献
3.
1 The standard drug for the treatment of arsenic poisoning is BAL (dimercaprol). BAL possesses marked side-effects and a low safety ratio, drawbacks which new BAL analogues, DMPS and DMSA, do not possess. 2 The efficacy of three chelating agents, BAL, DMPS and DMSA, has been evaluated as a treatment for systemic organic arsenic poisoning, induced by intravenous dichloro(2-chlorovinyl)arsine (lewisite) administration to rabbits. Equimolar dosing schedules were used based upon realistic doses for the most toxic agent, BAL. 3 It was concluded that all three dimercapto chelating agents provided significant protection against the lethal systemic effects of lewisite, and, under the test conditions reported here, there was no significant difference between them in therapeutic efficacy. 4 The cause of mortality following intravenous lewisite in treated and untreated rabbits was pulmonary damage. 5 It is considered that DMPS and DMSA are worthy of further study as replacements for BAL in the treatment of systemic poisoning by lewisite. 相似文献
4.
5.
6.
Jane Maienschein James L. W. West Betty Bright 《Pediatric nephrology (Berlin, Germany)》2004,19(12):1437-1438
7.
We report an adult female with a rare giant choledochal cyst. The patient presented following a normal pregnancy with the classical triad of an abdominal mass associated with jaundice and right upper quadrant abdominal pain. The cyst was excised using an intramural technique and biliary reconstruction achieved with a Roux-en-Y hepaticojejunostomy. Our patient has remained well with no evidence of malignancy over a 12 year review period. The aetiology and current management of this condition are discussed. 相似文献
8.
9.
Na+ dependence of in vitro pancreatic amylase release 总被引:1,自引:0,他引:1
10.
Determination of optimal cryoprotectants and procedures for their addition and removal from human spermatozoa 总被引:9,自引:7,他引:9
The objective was to test the hypothesis that the optimal cryoprotective
agent for cryopreservation of human spermatozoa would be a solute for which
cells have the highest plasma membrane permeability, resulting in the least
amount of volume excursion during its addition and removal. To test this
hypothesis, theoretical simulations were performed using membrane
permeability coefficients to predict optimal procedures for the addition
and removal of a cryoprotectant. Simulations were performed using data from
four different cryoprotectants: (i) glycerol, (ii) dimethyl sulphoxide,
(iii) propylene glycol and (iv) ethylene glycol. Thermodynamic formulations
were applied to determine approaches for the addition and removal of 1 M
and 2 M final concentrations of cryoprotectant, allowing the spermatozoa to
maintain a cell volume within their osmotic tolerance limits. Based on
these data, ethylene glycol was predicted to be optimal for minimizing
volume excursions among the solutes evaluated. These predictions were then
experimentally tested using glycerol as the control cryoprotectant and
ethylene glycol as the experimental cryoprotectant. The results indicate
that there was a higher (P < 0.05) recovery of motile spermatozoa after
cryopreservation when using 1 M ethylene glycol than with 1 M glycerol,
supporting the hypothesis that use of the cryoprotectant for which the cell
has the highest permeability will result in higher cell survival.
相似文献